• Olink® Target 96 Inflammation Panels

    Thoroughly validated, high-performance protein biomarker panels for inflammation studies.

    Olink® Target 96 panels specialize in key disease areas and important biological processes, and accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.

    icon-2

    Key features & benefits

    • Allows for simultaneous analysis of 92 protein biomarkers
    • Uses only 1 µL of biological sample
    • Exceptional data quality through relative (NPX) quantification
    • qPCR readout with unparalleled sensitivity, specificity, and precision
    • All assays are subject to Olink’s strict technical validation and quality control procedures

    The Olink Target 96 Inflammation panel offers a broad selection of proteins associated with inflammatory and immune response processes. Categorization of the proteins included in the panel was carried out via referral to widely used public-access bioinformatic databases, including Uniprot, Human Protein Atlas, Gene Ontology (GO) and DisGeNET.

    Target

    Accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.
    Learn more about the Olink Target platform.

    Olink® Target 96 & 48

    How does it work?

    The unique technology behind the Olink platforms, Proximity Extension Assay (PEA) technology, is an innovative dual recognition, DNA-coupled methodology providing exceptional readout specificity. PEA enables high multiplex, rapid throughput biomarker analysis without compromising on data quality.

    PEA-image

    Read more about how Olink technology delivers this scale of multiplexing and sample throughput without compromising on data quality or assay robustness.

    Proximity Extension Assay (PEA) technology

    The Olink biomarker assay panels are available with the flexibility to best suit your needs. You can choose whether to purchase the panels as kits and run them in your own lab, or send your sample the experts at one of the many trained labs around the world offering sample analysis service.

    Panels

    Olink Target 96 Inflammation ( 92 )

    This represents the most extensive panel available on the market for proteins associated with inflammatory diseases and related biological processes, enabling investigation of protein signatures with high efficiency and robustness and accelerates the speed of finding new and relevant human protein biomarkers related to inflammation. The panel is compiled to detect a selection of already established as well as exploratory biomarkers within the inflammation research field.

    The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.

    ';
    Adenosine deaminase (ADA)
    ';
    Artemin (ARTN)
    ';
    Axin-1 (AXIN1)
    ';
    Beta-nerve growth factor (NGF)
    ';
    C-C motif chemokine 13 (CCL13)
    ';
    C-C motif chemokine 19 (CCL19)
    ';
    C-C motif chemokine 2 (CCL2)
    ';
    C-C motif chemokine 20 (CCL20)
    ';
    C-C motif chemokine 23 (CCL23)
    ';
    C-C motif chemokine 25 (CCL25)
    ';
    C-C motif chemokine 28 (CCL28)
    ';
    C-C motif chemokine 3 (CCL3)
    ';
    C-C motif chemokine 4 (CCL4)
    ';
    C-C motif chemokine 7 (CCL7)
    ';
    C-C motif chemokine 8 (CCL8)
    ';
    C-X-C motif chemokine 10 (CXCL10)
    ';
    C-X-C motif chemokine 11 (CXCL11)
    ';
    C-X-C motif chemokine 5 (CXCL5)
    ';
    C-X-C motif chemokine 6 (CXCL6)
    ';
    C-X-C motif chemokine 9 (CXCL9)
    ';
    CUB domain-containing protein 1 (CDCP1)
    ';
    Caspase-8 (CASP8)
    ';
    Cystatin-D (CST5)
    ';
    Delta and Notch-like epidermal growth factor-related receptor (DNER)
    ';
    Eotaxin (CCL11)
    ';
    Eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1)
    ';
    Fibroblast growth factor 19 (FGF19)
    ';
    Fibroblast growth factor 21 (FGF21)
    ';
    Fibroblast growth factor 23 (FGF23)
    ';
    Fibroblast growth factor 5 (FGF5)
    ';
    Fms-related tyrosine kinase 3 ligand (FLT3LG)
    ';
    Fractalkine (CX3CL1)
    ';
    Glial cell line-derived neurotrophic factor (GDNF)
    ';
    Growth-regulated alpha protein (CXCL1)
    ';
    Hepatocyte growth factor (HGF)
    ';
    Interferon gamma (IFNG)
    ';
    Interleukin-1 alpha (IL1A)
    ';
    Interleukin-10 (IL10)
    ';
    Interleukin-10 receptor subunit alpha (IL10RA)
    ';
    Interleukin-10 receptor subunit beta (IL10RB)
    ';
    Interleukin-12 subunit beta (IL12B)
    ';
    Interleukin-13 (IL13)
    ';
    Interleukin-15 receptor subunit alpha (IL15RA)
    ';
    Interleukin-17A (IL17A)
    ';
    Interleukin-17C (IL17C)
    ';
    Interleukin-18 (IL18)
    ';
    Interleukin-18 receptor 1 (IL18R1)
    ';
    Interleukin-2 (IL2)
    ';
    Interleukin-2 receptor subunit beta (IL2RB)
    ';
    Interleukin-20 (IL20)
    ';
    Interleukin-20 receptor subunit alpha (IL20RA)
    ';
    Interleukin-22 receptor subunit alpha-1 (IL22RA1)
    ';
    Interleukin-24 (IL24)
    ';
    Interleukin-33 (IL33)
    ';
    Interleukin-4 (IL4)
    ';
    Interleukin-5 (IL5)
    ';
    Interleukin-6 (IL6)
    ';
    Interleukin-7 (IL7)
    ';
    Interleukin-8 (CXCL8)
    ';
    Interstitial collagenase (MMP1)
    ';
    Kit ligand (KITLG)
    ';
    Leukemia inhibitory factor (LIF)
    ';
    Leukemia inhibitory factor receptor (LIFR)
    ';
    Lymphotoxin-alpha (LTA)
    ';
    Macrophage colony-stimulating factor 1 (CSF1)
    ';
    NAD-dependent protein deacetylase sirtuin-2 (SIRT2)
    ';
    Natural killer cell receptor 2B4 (CD244)
    ';
    Neurotrophin-3 (NTF3)
    ';
    Neurturin (NRTN)
    ';
    Oncostatin-M (OSM)
    ';
    Programmed cell death 1 ligand 1 (CD274)
    ';
    Protein S100-A12 (S100A12)
    ';
    Protransforming growth factor alpha (TGFA)
    ';
    STAM-binding protein (STAMBP)
    ';
    Signaling lymphocytic activation molecule (SLAMF1)
    ';
    Stromelysin-2 (MMP10)
    ';
    Sulfotransferase 1A1 (SULT1A1)
    ';
    T-cell differentiation antigen CD6 (CD6)
    ';
    T-cell surface glycoprotein CD5 (CD5)
    ';
    T-cell surface glycoprotein CD8 alpha chain (CD8A)
    ';
    Thymic stromal lymphopoietin (TSLP)
    ';
    Transforming growth factor beta-1 proprotein (TGFB1)
    ';
    Tumor necrosis factor (TNF)
    ';
    Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
    ';
    Tumor necrosis factor ligand superfamily member 11 (TNFSF11)
    ';
    Tumor necrosis factor ligand superfamily member 12 (TNFSF12)
    ';
    Tumor necrosis factor ligand superfamily member 14 (TNFSF14)
    ';
    Tumor necrosis factor receptor superfamily member 11B (TNFRSF11B)
    ';
    Tumor necrosis factor receptor superfamily member 5 (CD40)
    ';
    Tumor necrosis factor receptor superfamily member 9 (TNFRSF9)
    ';
    Urokinase-type plasminogen activator (PLAU)
    ';
    Vascular endothelial growth factor A (VEGFA)
    ';

    Related documents

    A benchtop system for protein biomarker analysis

    Olink® Signature Q100 is a user-friendly instrument for readout of all Olink® Target and Olink® Focus protein biomarker panels. Learn more about this benchtop solution and how to streamline your protein biomarker analysis.

    Olink® Signature Q100

    Search for protein biomarker

    Browse the entire Olink library of high quality, thoroughly validated protein biomarker assays. Search by Uniprot ID, protein name, alternative protein name or gene name.

    Proteomics-and-transcriptomics

    Validation Data

    To view more detailed information on Olink panels, you can download full validation data information for all Olink panels in the document download center.

    Assay-Validation

    Manuals & instructions

    Access all the latest technical user documentation to learn more about the functionalities of Olink products and solutions, including manuals, short instructions and guidelines.

    Product-news

    Sample analysis service

    Our analysis service offers high-capacity analysis of your samples using our Olink Explore or Olink Target platforms for protein biomarker analysis.

    Sample analysis service

    Frequently Asked Questions

    See what other visitors asked, to learn more about Olink technology, services and science. Search our library of information or contact our Customer Support for assistance.

    FAQ-inline-1000x563

    2947

    Biomarker assays

    ~881 million

    Protein data points generated

    1196

    Publications listed on website

    Contact us!